Latest News & Updates
Breaking News
11 hours ago
Pharma Now Editorial Team
Other trending news you may like to read
FDA AEMS Flags 20-Plus Q1 2026 Safety Signals Across Injectables, Oncology, and Neurology Classes
FDA's Q1 2026 AEMS release flags 20-plus safety signals across injectables, oncology, and neurology, with most under active regulatory evaluation.
Pharma Now Editorial Team
Orca Bio Gains FDA Approval for Tregzi in Matched Donor HSCT for Hematologic Malignancies
FDA approves Orca Bio's Tregzi, a three-component allogeneic cell therapy, for matched donor HSCT in adults with hematologic malignancies.
Simantini Singh Deo
George Medicines Appoints Brendan Walsh as SVP of Supply Chain and Technical Operations
George Medicines names Brendan Walsh SVP of Supply Chain to govern GMRx2's multi-CMO, eight-territory commercial network.
Vaibhavi M.
Tonix Pharmaceuticals Enrolls First Patient in Phase 2 HORIZON Study of TNX-102 SL for MDD
Tonix Pharmaceuticals enrolls first patient in HORIZON, a Phase 2 study of TNX-102 SL for MDD, extending its FDA-approved sublingual fibromyalgia tablet into a second indication.
Vaibhavi M.
